Dr. Reddy's launches generic Adcirca tablets
Dr. Reddy’s is introducing its generic Adcirca (tadalafil). The generic of Eli Lilly's branded drug is indicated to treat pulmonary arterial hypertension.
The Adcirca brand and generic had a market value of roughly $490 million, for the most recent twelve months ending in November 2018, according to IQVIA data.
Dr. Reddy’s tadalafil tablets are available in a 20-mg dosage strength in 60-count bottle size.
The Adcirca brand and generic had a market value of roughly $490 million, for the most recent twelve months ending in November 2018, according to IQVIA data.
Dr. Reddy’s tadalafil tablets are available in a 20-mg dosage strength in 60-count bottle size.